Publications by authors named "K T Muminova"

Article Synopsis
  • Preeclampsia (PE) is a serious pregnancy condition affecting up to 5% of pregnant women, leading to significant health risks for both mothers and newborns, with a need for better early risk assessment methods.
  • A study identified ten maternal serum proteins as potential early markers for PE at 11-13 weeks gestation, with most of these proteins having connections to PE from previous research.
  • A Support Vector Machine (SVM) model using 19 proteins showed a high predictive power (AUC of 0.91, 87% sensitivity, 95% specificity) for early PE detection, outperforming standard screening methods.
View Article and Find Full Text PDF

Introduction: The role of the TGFβ signaling pathway, an important cascade responsible for the anti-inflammatory polarization of macrophages, in the development of both early- and late-onset preeclampsia (eoPE and loPE), remains poorly understood. In this study, we examined the components of the TGFβ signaling cascade and macrophage markers within placental tissue in normal pregnancy and in PE.

Methods: Patients with eoPE, loPE, and normal pregnancy were enrolled in the study (n = 10 in each group).

View Article and Find Full Text PDF

Antihypertensive therapy is an essential part of management of patients with preeclampsia (PE). Methyldopa (Dopegyt) and nifedipine (Cordaflex) are basic medications of therapy since they stabilize blood pressure without affecting the fetus. Their effect on the endothelium of placental vessels has not yet been studied.

View Article and Find Full Text PDF

This paper provides an assessment of molecular and functional changes in blood vessels, and a description of vascular patterns during preeclampsia (PE). Patients with normal pregnancy, and pregnancy complicated by PE at earlier (20-34 weeks) and later terms (≥34 weeks) underwent a 24 h monitoring of blood pressure, central hemodynamics, arterial stiffness, and myocardial function. The blood levels of the structural components of endothelial glycocalyx (eGC): syndecan-1 (SDC 1), heparan sulfate proteoglycan 2 (HSPG2), and hyaluronic acid (HA) were determined.

View Article and Find Full Text PDF